Loading...
Loading...
Available on 1 platform
Sign in to view source links and access this dataset
A collection of 4,950 clinical isolates of Enterobacterales and Pseudomonas aeruginosa from patients in Kuwait, Qatar, the United Arab Emirates, and Oman between 2020 and 2024. The dataset, authored by Mark G. Wise and last updated in 2026, reports in vitro susceptibility results for ceftolozane/tazobactam, imipenem/relebactam, and comparator antimicrobial agents. Molecular characterization data for acquired β-lactamases is included for most non-susceptible isolates.
The primary data file is a DOCX document (23.9 KB), which is a small file likely containing summarized results in a report format rather than raw, machine-readable data tables.